Charles Moen Rice, Iii

University City, MO, United States of America

Charles Moen Rice, Iii

wikipediaNobel Prize

This inventor holds 14 USPTO granted patents. Top assignees: Washington University, The Rockefeller University. Active years: 1993-2015. Nobel Prize laureate.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles Moen Rice, Iii. Retrieved from https://idiyas.com/inventor/charles-moen-rice-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 204(Granted Patents)


Location History:

  • University City, MO (US) (1993 - 2007)
  • New York, NY (US) (2008 - 2015)

Company Filing History:


Years Active: 1993-2015

Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Charles Moen Rice, III

Introduction

Charles Moen Rice, III is a prominent inventor based in University City, MO (US). He has made significant contributions to the field of biomedical research, particularly in understanding the mechanisms of Hepatitis C Virus (HCV) entry into human cells. With a total of 14 patents to his name, Rice's work has paved the way for potential therapeutic interventions against HCV.

Latest Patents

Among his latest patents, Rice has developed groundbreaking inventions related to HCV. One notable patent identifies Occludin as an essential cell entry factor for HCV. This discovery reveals that Occludin can render non-human cells susceptible to HCV infection and is crucial for the susceptibility of human cells. His work includes methods for inhibiting HCV infection, transgenic animal models for studying HCV pathogenesis, and kits for identifying compounds that can prevent HCV interactions with Occludin. Another significant patent focuses on the Claudin-1 protein, which functions as a co-receptor for HCV entry. This invention provides methods for inhibiting HCV infections by targeting Claudin-1 and includes the development of kits and agents that can interfere with HCV interactions.

Career Highlights

Rice has had a distinguished career, working at prestigious institutions such as Washington University and The Rockefeller University. His research has not only advanced scientific understanding but has also contributed to the development of potential treatments for HCV.

Collaborations

Throughout his career, Rice has collaborated with notable scientists, including Alexander A. Kolykhalov and Matthew Evans. These collaborations have further enriched his research and expanded the impact of his inventions.

Conclusion

Charles Moen Rice, III's innovative work in the field of HCV research exemplifies the critical role of inventors in advancing medical science. His contributions continue to influence the development of therapeutic strategies against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…